Long-term surveillance of patients with multiple sclerosis to report progressive multifocal leukoencephalopathy and other serious opportunistic infections among patients treated with natalizumab First published 03/02/2022 Last updated 19/09/2025 EU PAS number:EUPAS45445 Study Finalised